Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
QTTB
Stock Latest News
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
3d ago
HD
LI
Premium
Market News
Why Is Q32 Bio Stock (QTTB) Up Today?
3d ago
QTTB
Premium
Company Announcements
Q32 Bio Sells ADX-097 to Akebia Therapeutics
3d ago
8K
QTTB
Premium
The Fly
Akebia Therapeutics announces establishment of rare kidney disease pipeline
3d ago
AKBA
QTTB
Premium
The Fly
Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront
3d ago
AKBA
QTTB
Premium
The Fly
Q32 Bio sells complement inhibitor ADX-097 to Akebia
3d ago
AKBA
QTTB
Premium
Company Announcements
Q32 Bio Inc. Faces Financial Challenges Amid Development Efforts
21d ago
QTTB
Premium
The Fly
Q32 Bio reports Q3 EPS (60c), consensus ($1.19)
21d ago
QTTB
Premium
Company Announcements
Q32 Bio Completes Enrollment for Alopecia Trial
1M ago
8K
QTTB
Premium
The Fly
Q32 Bio completes enrollment in Part B of SIGNAL-AA trial
1M ago
QTTB
Premium
Company Announcements
Q32 Bio Inc.’s Promising Alopecia Areata Treatment Trial Update
3M ago
QTTB
Premium
The Fly
Eight option delistings on August 18th
4M ago
ABTS
ALUR
Premium
Company Announcements
Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
4M ago
QTTB
Premium
Company Announcements
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
4M ago
QTTB
Premium
Company Announcements
Q32 Bio Appoints New Interim Chief Medical Officer
5M ago
8K
QTTB
Premium
The Fly
Q32 Bio chief medical officer Jason Campagna to depart
5M ago
QTTB
Premium
The Fly
Oxford Biomedica completes acquisition of remaining stake in U.S. subsidiary
5M ago
QTTB
Premium
Company Announcements
Q32 Bio Stockholders Approve Key Proposals at Annual Meeting
6M ago
8K
QTTB
Premium
Company Announcements
Q32 Bio Inc. Reports Q1 2025 Financial Results
7M ago
QTTB
Premium
The Fly
Q32 Bio granted Fast Track designation for bempikibart
7M ago
QTTB
Premium
Company Announcements
Q32 Bio Board Member Mark Iwicki Resigns
7M ago
8K
QTTB
Premium
The Fly
Q32 Bio doses first patient in both parts of SIGNAL-AA trial
8M ago
QTTB
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
